While many groups are working to conquer these limitations (7, 43, 83, 84), the best example being the success of the COVID mRNA vaccines (85), work is still needed to obtain a successful nanoparticle-based cancer therapy that can generate robust CD8+T cell responses (83). Here, CD8A is linked to cancer.